LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway
Abstract Background: Studies have shown that cancer susceptibility candidate 11 (CASC11), a newly discovered long non-coding RNA (lncRNA), was aberrantly overexpressed in hepatic carcinoma, gastric cancer and colorectal cancer. However, its effects on cervical cancer has been kept unknown up to now...
Guardado en:
Autores principales: | Hsu,Wenchan, Liu,Lifen, Chen,Xin, Zhang,Ying, Zhu,Weipei |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad de Biología de Chile
2019
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602019000100231 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Long noncoding RNA CASC2 predicts the prognosis of glioma patients and functions as a suppressor for gliomas by suppressing Wnt/β-catenin signaling pathway
por: Wang R, et al.
Publicado: (2017) -
Super-enhancer-driven lncRNA-DAW promotes liver cancer cell proliferation through activation of Wnt/β-catenin pathway
por: Weicheng Liang, et al.
Publicado: (2021) -
β-Catenin: oncogenic role and therapeutic target in cervical cancer
por: Wang,Bingqi, et al.
Publicado: (2020) -
Expression of Wnt and β-Catenin in Mouse Tooth Germs and Chick Facial Primordia: A Comparison
por: Louryan,S., et al.
Publicado: (2018) -
LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α
por: Yu H, et al.
Publicado: (2019)